Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
INDV
#1358
Indivior Pharmaceuticals, Inc. - Common Stock
40.2
1
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.72%
Monthly Change
+3.93%
6 month change
+19.67%
Year Change
+19.67%
Previous Close
40.5
0
Open
40.2
1
Low
40.2
1
High
40.2
1
Volume
191
Markets
US Stock Market
Healthcare
Drug Manufacturers—Specialty & Generic
INDV
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2023
2024
2025
Current
Key stats
Total common shares outstanding
136.53 M
124.66 M
125.07 M
121.92 M
Valuation ratios
Enterprise value
1.8 B
1.56 B
4.58 B
5.24 B
Price to earnings ratio
—
621.5
21.88
20.72
Price to sales ratio
—
1.39
3.71
4.01
Price to cash flow ratio
—
45.92
-170.1
-47.82
Price to book ratio
—
-4.75
-46.86
-7.31
Enterprise value to EBITDA ratio
—
25.63
6.38
15.49
Profitability ratios
Return on assets %
0
0
0.17
0.07
Return on equity %
—
-0.01
-2.14
-0.62
Return on invested capital %
—
2.31
75.91
36.19
Gross margin %
82.98
80.56
80.23
87.38
Operating margin %
-0.37
2.69
21.15
43.22
EBITDA margin %
—
5.13
58.35
44.16
Net margin %
0.18
0.17
16.95
28.08
Liquidity ratios
Quick ratio
0.86
0.7
0.55
0.66
Current ratio
0.97
0.89
0.71
0.86
Inventory turnover
1.31
1.44
1.61
0.26
Asset turnover
0.56
0.73
1.03
0.26
Solvency ratios
Debt to assets ratio
—
0.24
0.24
0.41
Debt to equity ratio
—
-0.91
-2.96
-3.38
Long term debt to total assets ratio
—
0.4
0.38
—
Long term debt to total equity ratio
—
-1.51
-4.68
—
Per share metrics
Operating cash flow per share
—
0.27
-0.21
-0.84
EBIT per share
—
0.24
5.62
2.57
EBITDA per share
—
0.46
5.65
2.65
Total debt per share
—
2.5
2.27
3.77
Cash per share
—
2.41
1.52
1.36
Net current asset value per share
—
6.31
5.09
5.17
Tangible book value per share
—
-2.66
-0.78
-1.13
Working capital per share
—
-0.75
-2.05
-0.87
Book value per share
—
-2.62
-0.77
-1.12
News
Broadcom Inks Pact With Meta, Leads 21 Top Performers Onto Best Stock Watchlists
Axsome Therapeutics, Exelixis, Incyte Among 20 New Stocks On IBD's Premier Watchlists
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
ACAD Stock Up as CHMP Backs Daybu for EU Approval in Rett Syndrome
Indivior Pharmaceuticals Inc. (INDV) is on the Move, Here's Why the Trend Could be Sustainable
Bull of the Day: Neurocrine Biosciences (NBIX)
IONS Out-Licenses ex-U.S. Rights for Rare Neurology Drug to Recordati
Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
IBD 50 Stock Indivior Breaks Out Amid Big Fund Ownership Expansion, Strong Profit Prospects
Reasons Why Investors Should Consider Betting on Indivior Stock
5 Small Drug Stocks to Invest in Amid a Biotech Comeback